{"transactions":[{"id":2199086,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-02T01:13:26.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022."}],"balance_after":75000,"derivative":{"exercise_price":1.57,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-027270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924322027270/doc4.xml","form_type":"4"}},{"id":2263750,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-19T20:20:27.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022."}],"balance_after":50000,"derivative":{"exercise_price":1.18,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-018807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924322018807/doc4.xml","form_type":"4"}},{"id":2388587,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T22:18:55.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022."}],"balance_after":75000,"derivative":{"exercise_price":3.19,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-22-006818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924322006818/doc4.xml","form_type":"4"}},{"id":2564072,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-09-20T21:00:10.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":5694,"price":6.73,"value":38320.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold solely to pay taxes due upon the vesting of restricted stock units, as disclosed by the reporting person on the Form 4 filed on September 16, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.87, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14306,"source":{"system":"sec-edgar","filing":"0000899243-21-036595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321036595/doc4.xml","form_type":"4"}},{"id":2567772,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-09-16T23:39:19.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 19, 2021, the reporting person was granted 40,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-21-036333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321036333/doc4.xml","form_type":"4"}},{"id":2710385,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-17T21:07:04.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exerciseable over four years, with 25% of this option vesting on April 19, 2022, and the remainder vesting in 36 equal monthly installments thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment has been filed to revise the vesting terms of Mr. Nichols' stock option, which were reported incorrectly on Mr. Nichols' prior Form 4. The corrected vesting schedule is included in Footnote 1 above."}],"balance_after":175000,"derivative":{"exercise_price":10.5,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-21-019632","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321019632/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-20"}},{"id":2744011,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":125011,"kind":"person","name":"Nichols David Wayne","position":1,"cik":"0001857488","reported_name":"Nichols David Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T21:04:31.000Z","date":"2021-04-19","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exerciseable over four years, with 25% of this option vesting on April 19, 2021, and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":175000,"derivative":{"exercise_price":10.5,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-21-016411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000089924321016411/doc4.xml","form_type":"4"}}]}